Literature DB >> 10843603

Recent advances in the chemistry of taxol.

D G Kingston1.   

Abstract

The history of the development of the important anticancer drug taxol (1) is briefly described, and recent studies of its chemistry and tubulin-binding conformation are then presented. Topics discussed include side chain attachment to baccatin III (3a), the effect of oxygenation of the taxane ring system on bioactivity, the importance of the oxetane ring for bioactivity, the synthesis of a C-6/C-4 bridged analogue, and the conformation of the side chain when taxol is bound in a complex with polymerized tubulin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10843603     DOI: 10.1021/np000064n

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  25 in total

1.  Fluorescent schweinfurthin B and F analogs with anti-proliferative activity.

Authors:  Joseph J Topczewski; Craig H Kuder; Jeffrey D Neighbors; Raymond J Hohl; David F Wiemer
Journal:  Bioorg Med Chem       Date:  2010-07-29       Impact factor: 3.641

2.  Poly(ethylene oxide)-block-polyphosphoester-graft-paclitaxel conjugates with acid-labile linkages as a pH-sensitive and functional nanoscopic platform for paclitaxel delivery.

Authors:  Jiong Zou; Fuwu Zhang; Shiyi Zhang; Stephanie F Pollack; Mahmoud Elsabahy; Jingwei Fan; Karen L Wooley
Journal:  Adv Healthc Mater       Date:  2013-08-30       Impact factor: 9.933

3.  CoMFA, HQSAR and molecular docking studies of butitaxel analogues with beta-tubulin.

Authors:  Suzanne L Cunningham; Albert R Cunningham; Billy W Day
Journal:  J Mol Model       Date:  2004-12-23       Impact factor: 1.810

Review 4.  Recent advances towards development and commercialization of plant cell culture processes for the synthesis of biomolecules.

Authors:  Sarah A Wilson; Susan C Roberts
Journal:  Plant Biotechnol J       Date:  2011-11-08       Impact factor: 9.803

5.  Molecular dynamics simulation and density functional theory studies on the active pocket for the binding of paclitaxel to tubulin.

Authors:  Sichuan Xu; Shaoming Chi; Yi Jin; Qiang Shi; Maofa Ge; Shu Wang; Xingkang Zhang
Journal:  J Mol Model       Date:  2011-05-03       Impact factor: 1.810

6.  Anticancer efficacy and toxicokinetics of a novel paclitaxel-clofazimine nanoparticulate co-formulation.

Authors:  Dwayne Koot; Duncan Cromarty
Journal:  Drug Deliv Transl Res       Date:  2015-06       Impact factor: 4.617

7.  Chemical conjugation of muramyl dipeptide and paclitaxel to explore the combination of immunotherapy and chemotherapy for cancer.

Authors:  Xuqin Li; Junli Yu; Song Xu; Nan Wang; Hongzhen Yang; Zheng Yan; Guifang Cheng; Gang Liu
Journal:  Glycoconj J       Date:  2007-12-27       Impact factor: 2.916

8.  Reporter nanoparticle that monitors its anticancer efficacy in real time.

Authors:  Ashish Kulkarni; Poornima Rao; Siva Natarajan; Aaron Goldman; Venkata S Sabbisetti; Yashika Khater; Navya Korimerla; Vineethkrishna Chandrasekar; Raghunath A Mashelkar; Shiladitya Sengupta
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-29       Impact factor: 11.205

9.  The final acylation step in taxol biosynthesis: cloning of the taxoid C13-side-chain N-benzoyltransferase from Taxus.

Authors:  Kevin Walker; Robert Long; Rodney Croteau
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-27       Impact factor: 11.205

Review 10.  Recent advances in the study of the bioactive conformation of taxol.

Authors:  Liang Sun; Carlos Simmerling; Iwao Ojima
Journal:  ChemMedChem       Date:  2009-05       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.